Skip to content
Indrayani Biotech logo

Indrayani Biotech

526445 BSE
₹8.00 down 0.22 (2.68%)
Market Cap
₹62.49 Cr
P/E
36.36

Indrayani Biotech (INDRANIB) share price was ₹8.22 at the 28 Oct 2026 close; market capitalisation ₹64.21 Cr; P/E (TTM) 37.36; sector FMCG. The share price fell 41.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue fell 25.3% year on year to ₹37.76 Cr and net profit was ₹0.98 Cr, against −₹8.53 Cr a year earlier (compared with Mar 2025). Promoters held 32.92% of Indrayani Biotech in Jun 2026, down 0.34 percentage points from Mar 2026. Its Tapetide Score is 49/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹8.22 −5.93 −41.91% 1Y

Key Fundamentals

MicrocapConsumer GoodsFMCG
Market Cap
₹62.49 Cr
P/E (TTM)
36.36
EBITDA
₹9.63 Cr
Return on Equity
-6.11%
Debt to Equity
1.75
Book Value
₹15.59
EPS (TTM)
₹0.22
52W High
₹16.47
52W Low
₹6.10

Price-based figures as of 29 Oct 2026, 10:43 IST · EPS basis: Consolidated · TTM

Peer Comparison

Fast Moving Consumer Goods › FMCG › Agricultural Products › Other Agricultural Products

LT Foods
₹379.5520.5813,180 Cr2.690.77%13.83%18.52%12,166 Cr640 Cr
KRBL
₹349.6510.558,003 Cr1.381.26%11.16%14.81%6,137 Cr758 Cr
Gujarat Ambuja Exports
₹143.9815.876,604 Cr1.840.21%9.23%12.46%6,110 Cr416 Cr
Kaveri Seed Company
₹685.0514.123,524 Cr1.740.73%16.86%17.00%1,302 Cr249 Cr
Trualt Bioenergy
₹373.1020.473,199 Cr1.980.00%6.14%10.77%2,823 Cr159 Cr
GRM Overseas
₹90.5023.211,875 Cr3.130.51%12.56%20.24%1,899 Cr77 Cr
Indrayani Biotech (this company)
₹8.0036.3662 Cr0.510.00%-6.11%3.64%152 Cr2 Cr
Median 7 companies₹349.6520.473,524 Cr1.840.51%11.16%14.81%2,823 Cr249 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

49 Average
Overall score

Data confidence 100/100

Category scores

Quality Strong 73
Returns, margins, earnings quality 22% weight
Valuation Average 47
Cheap vs sector & own history 24% weight
Growth Average 46
Sales & profit trajectory 9% weight
Financial Health Poor 21
Solvency, leverage, coverage 9% weight
Momentum Poor 27
Trend strength, vol-adjusted 12% weight
Ownership Average 46
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 1.08 times its book value

Weaknesses

7
  • Company has low interest coverage ratio.
  • Promoter holding is low: 32.9%
  • Company has a low return on equity of 1.21% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.4.57 Cr.
  • Company has high debtors of 155 days.
  • Promoter holding has decreased over last 3 years: -11.9%

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
12
Neutral
7
Bullish
0

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
3.32% higher than 3Y

change over 1 year

Net Income Growth
-104% lower than 3Y

change over 1 year

Cash Flow Change
77.79%

change over 1 year

EBITDA Margin Change
-3.98%

change over 1 year Operating margin 5.88% · Mar 2026

Quarterly Results

Particulars Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
49.25
42.31
40.44
39.09
44.38
31.53
30.81
17.32
50.57
29.1
35.95
35.01
37.76
Expenses
46.07
39.77
33.15
35.64
34.21
25.55
25.7
14.4
56.31
26.92
33.5
32.22
35.54
Operating Profit
3.18
2.54
7.29
3.45
10.17
5.98
5.11
2.92
-5.74
2.18
2.45
2.79
2.22
OPM %
6.46%
6%
18.03%
8.83%
22.92%
18.97%
16.59%
16.86%
-11.35%
7.49%
6.82%
7.97%
5.88%
Other Income
2.05
0.01
0.09
0.08
1.03
0.04
0.3
0
2.78
1.06
1.8
0.83
0.88
Interest
2.23
2.03
0.93
1.41
5.51
0.83
1.42
1.03
7.07
2.17
1.89
2.47
3.08
Depreciation
1.15
0.9
0.91
1.03
0.96
4.25
2.79
1.46
-1.72
0.86
1.3
1.01
1.13
PBT
1.85
-0.38
5.54
1.09
4.73
0.94
1.2
0.43
-8.31
0.21
1.06
0.14
-1.11
Tax %
21.62%
15.79%
0%
0%
0%
9.57%
-1.67%
18.6%
2.53%
23.81%
14.15%
21.43%
-187.39%
Net Profit
1.44
-0.45
5.54
1.08
4.73
0.85
1.22
0.35
-8.53
0.16
0.91
0.12
0.98
EPS (₹)
0.18
-0.08
0.94
0.13
0.5
0.11
0.16
0.03
-1.09
0.02
0.05
0.02
0.13
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0
39
58
50
21
61
163
165
130
138
Expenses
0
39
57
47
26
54
145
142
124
128
Operating Profit
0
1
1
3
-5
7
17
24
6
10
OPM %
-105%
1.9%
0.9%
6%
-24%
11%
11%
14%
4.9%
7%
Other Income
0
0
0
0
-4
0
4
1
3
5
Interest
0
0
0
1
2
2
6
10
12
10
Depreciation
0
0
0
1
0
1
3
4
3
4
PBT
0
0
0
1
-11
4
12
11
-6
0
Tax %
0%
150%
300%
0%
0%
0%
3%
5%
6%
-620%
Net Profit
0
0
0
1
-11
4
12
10
-6
2
EPS (₹)
—
-0.08
-0.1
1.31
-1.91
0.76
1.49
0.81
-0.78
0.28
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6
4
4
4
34
34
34
46
46
46
Reserves
-6
0
0
27
-15
-10
12
22
27
27
Borrowings
0
0
0
14
16
19
79
113
137
128
Other Liabilities
1
6
9
7
5
8
31
54
58
52
Total Liabilities
1
10
12
51
40
51
156
234
268
253
Fixed Assets
1
6
6
17
15
17
57
62
58
60
CWIP
0
0
0
14
14
13
14
20
26
27
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
0
4
7
21
11
22
85
151
184
166
Total Assets
1
10
12
51
40
51
156
234
268
253
Figures in ₹ Crores

Cash Flow

Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
1
2
6
0
4
16
-30
-7
32
Investing
—
-3
0
-4
-1
-1
-47
-16
25
-13
Financing
—
2
-1
-1
0
-3
33
44
-18
-15
Net Cash Flow
—
0
1
1
-1
1
2
-2
0
4
Free Cash Flow
—
-2
2
2
0
3
-25
-47
-8
23
CFO/OP
—
122
331
215
-5
61
94
-128
-124
328
Figures in ₹ Crores

Ratios

Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
26
26
52
84
84
67
87
165
155
Inventory Days
—
—
—
57
25
14
44
159
182
147
Days Payable
—
—
—
70
77
52
81
141
104
55
Cash Conversion Cycle
—
26
26
38
32
46
30
106
243
247
Working Capital Days
—
-22
-19
30
-59
-12
6
127
211
163
ROCE %
—
28%
12%
—
-13%
16%
23%
14%
3%
4%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Indrayani Biotech insights

61 extracted metrics + investor summaries across FY09–FY26.

Shareholding Pattern

DIIs3.13%Public49.48%Others14.47%Promot.32.92%As ofJun 2026
24.82% of promoter holding pledged as of 14 Oct 2026

Documents

Frequently Asked Questions about Indrayani Biotech

What does Indrayani Biotech Ltd do?
Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]
Where is Indrayani Biotech Ltd (INDRANIB) listed?
Indrayani Biotech Ltd trades under code 526445 on the BSE.
Which sector does Indrayani Biotech Ltd belong to?
Indrayani Biotech Ltd is classified under the FMCG sector, in the Agricultural Products industry.
What is the market capitalisation of Indrayani Biotech Ltd?
Indrayani Biotech Ltd has a market capitalisation of ₹62.49 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Indrayani Biotech Ltd?
Indrayani Biotech Ltd trades at a PE ratio of 36.36 as of 29 Oct 2026, on earnings per share of ₹0.22, against a book value of ₹15.59 per share.
What is the 52-week high and low of Indrayani Biotech Ltd?
Over the last 52 weeks Indrayani Biotech Ltd has traded between ₹6.1 and ₹16.47 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Indrayani Biotech Ltd?
Indrayani Biotech Ltd reported a return on equity of -6.11%. Its debt-to-equity ratio is 1.75.

Company Information

Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]

Website indrayani.com
Listed 1994-02-14
Face Value ₹ 10
Shares Outstanding 7,81,10,599

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526445.md for Indrayani Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Agri & Food Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month